Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Fundación Huésped, Buenos Aires, Argentina
Fundação Oswaldo Cruz.Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidad de Chile, Fundación Arriarán, Santiago, Chile
Instituto Hondureño de Seguridad Social and Hospital Escuela, Tegucigalpa, Honduras
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States
Vanderbilt University School of Medicine, Nashville, TN, United States

Resumen en ingles

Cryptococcal meningitis (CM) is associated with substantial mortality in HIV-infected patients. Optimal timing of antiretroviral therapy (ART) in persons with CM represents a clinical challenge, and the burden of CM in Latin America has not been well described. Studies suggest that early ART initiation is associated with higher mortality, but data from the Americas are scarce.

Palabras clave en ingles

Meningitis, Cryptococcal
AIDS
HIV
Latin America

DeCS

Meningite Criptocócica
Síndrome de Imunodeficiência Adquirida
HIV
América Latina

Editor

Elsivier

Referencia

CRABTREE RAMÍREZ, B. et al. Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas. International Journal of Infectious Diseases, v. 63, p. 57-63, 2017.

DOI

10.1016/j.ijid.2017.08.004

ISSN

1201-9712

Por favor, use este identificador para citar o enlazar este ítem: https://www.arca.fiocruz.br/handle/icict/25787

Tipo

Derechos de autor

Acceso abierto

Colecciones

Compartir

Estadísticas

Metadatos

Autor

Afiliación